Globe Newswire

Tourism Calgary welcomes Alisha Reynolds as new CEO May 6, 2024 11:26AM

Calgary, AB, May 06, 2024 (GLOBE NEWSWIRE) -- After an intensive search and competitive selection process, Tourism Calgary welcomes Alisha Reynolds as the organization’s new Chief Executive Officer. Reynolds will formally join Tourism Calgary on June 3, 2024, initiating the leadership transition from current CEO Cindy Ady, who announced her retirement late last year. 

“We are thrilled to have one of the industry’s rising stars join Tourism Calgary as our new... (continue reading...)

Prison Fellowship’s Statement After United States Senate Declares April 2024 as Second Chance Month May 6, 2024 11:25AM

Washington, D.C., May 06, 2024 (GLOBE NEWSWIRE) -- Prison Fellowship, the nation’s largest Christian nonprofit serving currently and formerly incarcerated people and their families, released the following statement after the United States Senate declared April 2024 as Second Chance Month. The resolution was led by Senators Klobuchar (D-MN), Cramer (R-ND), Capito (R-WV) and Markey (D-MA).

“With this gesture, the U.S. Senate has recognized that people with a... (continue reading...)

Holding(s) in Company May 6, 2024 11:25AM

Reykjavik, May 06, 2024 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:Amaroq Minerals Ltd.1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)Non-UK issuerX2. Reason for the notification (please mark the appropriate box or boxes with an “X”)An acquisition... (continue reading...)

Kymanox Announces Evan Edwards as President May 6, 2024 11:16AM

Morrisville, North Carolina USA, May 06, 2024 (GLOBE NEWSWIRE) -- Kymanox®, a leading provider of product development, engineering, quality, regulatory and technical solutions exclusively serving the Life Science industry, is pleased to announce that Evan Edwards has been promoted to President. This organizational change allows Kymanox to amplify the customer experience and further benefit from Evan’s expertise in innovation and leadership. This... (continue reading...)

Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine May 6, 2024 11:16AM

Phase 2 ORCA-V1 trial showed treatment with cytisinicline more than doubled odds of quitting e-cigarettes compared with placebo  

Cytisinicline treatment well tolerated with no serious adverse events reported and excellent compliance to study treatment

Achieve expects to conduct an End-of-Phase 2 Meeting with the FDA later this year to discuss Phase 3 trial plans

SEATTLE and VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc.... (continue reading...)